Post-IPO Equity - Assembly Biosciences
Investment Firm
Overview
Assembly Biosciences, Inc. is a public biotechnology company and provider of oral biologic therapeutics.
Announced Date
Jun 17, 2024
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
Round Details and Background
Assembly Biosciences raised $12600000 on 2024-06-17 in Post-IPO Equity
Assembly Biosciences, Inc. is a public biotechnology company and provider of oral biologic therapeutics.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 17, 2023 |  Post-IPO Equity - Assembly Biosciences | 1 | - | 15.2M |
| Jul 01, 2018 | Post-IPO Equity - Assembly Biosciences | - | 166.0M | |
| Jul 11, 2018 | Post-IPO Equity - Assembly Biosciences | - | 144.0M | |
| Jun 17, 2024 | Post-IPO Equity - Assembly Biosciences | 2 | - | 12.6M |
Recent Activity
There is no recent news or activity for this profile.